None listed
Conditions
Interventions
Intervention1: Better Heart: To support the long-term health promotion goals of the study, we will provide basic hypertension counseling to participants in all study groups. Participants will be rand
and (2) no financial
incentives or a financial incentive for clinic-based confirmatory screening for hypertension. The total duration of the study will be roughly two years based on the anticipated ti
Sponsors
National Heart Lung and Blood Institute National Institutes of Health USA
Eligibility
Inclusion criteria
Inclusion criteria: For the randomized trial, we will enroll individuals who meet the following inclusion criteria: Age =30 years, elevated BP (systolic BP =140 mmHg or diastolic BP =90 mmHg) measured at home by trained research assistants, and no prior physician diagnosis of hypertension (self-reported). We have chosen to focus on those aged =30 years as this is the official age cutoff used for home-based and opportunistic hypertension screening in India.
Exclusion criteria
Exclusion criteria: We will exclude individuals who meet the following criteria: Self-reported prior history of stroke or myocardial infarction, alcohol abuse, drug abuse, self-reported hyperthyroidism, and self-reported kidney disease. There will be no exclusions based on sex or gender. Since hypertension may affect any person regardless of their sex/gender, it is important that study participants are recruited irrespective of their sex or gender.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome will be assessed at 3 months. The primary outcome will be the receipt of confirmatory blood pressure measurement from a physician at a PHC. This is a binary variable that will be assessed by study staff members based at each PHC. As noted above, the staff will be tasked with recording whether study participants attended the PHC in the three months after enrollment.Timepoint: baseline;12 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| The secondary outcome will be assessed at 6 months. About 6 months from enrolment, the study team will schedule an appointment with participants to ask them some additional questions & measure their blood pressure again. The secondary outcome is an indicator of whether the participant received treatment & had controlled BP (140/90 mmHg) at 6 months. This will be assessed during the 6-month follow-up visit.Timepoint: baseline, 24 weeks | — |
Countries
India
Contacts
Public ContactDr Nikhil Tandon
All India Institute of Medical Sciences
Outcome results
None listed